126 related articles for article (PubMed ID: 19727726)
1. Progressive multifocal leukoencephalopathy: a report of three cases in HIV-negative patients with non-Hodgkin's lymphomas treated with rituximab.
Tuccori M; Focosi D; Maggi F; Cosottini M; Meini B; Lena F; Blandizzi C; Del Tacca M; Petrini M
Ann Hematol; 2010 May; 89(5):519-22. PubMed ID: 19727726
[No Abstract] [Full Text] [Related]
2. Progressive multifocal leukoencephalopathy after rituximab in a case of non-Hodgkin lymphoma.
Kranick SM; Mowry EM; Rosenfeld MR
Neurology; 2007 Aug; 69(7):704-6. PubMed ID: 17698796
[No Abstract] [Full Text] [Related]
3. Alpha-interferon therapy in a case of probable progressive multifocal leukoencephalopathy.
Colosimo C; Lebon P; Martelli M; Tumminelli F; Mandelli F
Acta Neurol Belg; 1992; 92(1):24-9. PubMed ID: 1546522
[TBL] [Abstract][Full Text] [Related]
4. Fatal progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma treated with rituximab.
Paues J; Vrethem M
J Clin Virol; 2010 Aug; 48(4):291-3. PubMed ID: 20558102
[TBL] [Abstract][Full Text] [Related]
5. Changes in the natural history of progressive multifocal leukoencephalopathy in HIV-negative lymphoproliferative disorders: impact of novel therapies.
García-Suárez J; de Miguel D; Krsnik I; Bañas H; Arribas I; Burgaleta C
Am J Hematol; 2005 Dec; 80(4):271-81. PubMed ID: 16315252
[TBL] [Abstract][Full Text] [Related]
6. Progressive multifocal leukoencephalopathy: report of three cases in HIV-negative hematological patients and review of literature.
Pelosini M; Focosi D; Rita F; Galimberti S; Caracciolo F; Benedetti E; Papineschi F; Petrini M
Ann Hematol; 2008 May; 87(5):405-12. PubMed ID: 18064459
[TBL] [Abstract][Full Text] [Related]
7. [Rituximab in the treatment of indolent non-Hodgkin's lymphoma].
Aurer I; Mitrović Z; Radman I; Kovacević-Metelko J; Nemet D; Serventi-Seiwerth R; Stern-Padovan R; Jakic-Razumović J; Nola M; Zupancić-Salek S; Sertić D; Labar B
Lijec Vjesn; 2004; 126(11-12):307-11. PubMed ID: 16082888
[TBL] [Abstract][Full Text] [Related]
8. Acute disseminated encephalomyelitis due to JC virus infection as the onset of non-Hodgkin's lymphoma.
Castro-Sánchez MV; Villagrán-García M; Romero-Imbroda J
Med Clin (Barc); 2019 May; 152(9):e49-e50. PubMed ID: 30337110
[No Abstract] [Full Text] [Related]
9. Non-HIV-related progressive multifocal leukoencephalopathy (PML): a tertiary cancer center experience.
Chowdhary S; Chalmers LM; Chamberlain M
J Neuroimaging; 2007 Jan; 17(1):69-73. PubMed ID: 17238872
[TBL] [Abstract][Full Text] [Related]
10. Inefficacy of rituximab in a case of low grade non-Hodgkin's lymphoma with cryoglobulinemia.
Baronciani D; Angelucci E; Gaziev J; Visani G
Haematologica; 2002 Jul; 87(7):ELT33. PubMed ID: 12091148
[No Abstract] [Full Text] [Related]
11. Rituximab monotherapy is effective in patients with poor risk refractory aggressive non-Hodgkin's lymphoma.
Rothe A; Schulz H; Elter T; Engert A; Reiser M
Haematologica; 2004 Jul; 89(7):875-6. PubMed ID: 15257947
[TBL] [Abstract][Full Text] [Related]
12. Depletion of B lymphocytes from cerebral perivascular spaces by rituximab.
Martin Mdel P; Cravens PD; Winger R; Kieseier BC; Cepok S; Eagar TN; Zamvil SS; Weber MS; Frohman EM; Kleinschmidt-Demasters BK; Montine TJ; Hemmer B; Marra CM; Stüve O
Arch Neurol; 2009 Aug; 66(8):1016-20. PubMed ID: 19667224
[TBL] [Abstract][Full Text] [Related]
13. [Non-cytostatic treatment of malignancies. Anti-CD20 monoclonal antibody (Rituximab, Mabthera) in the treatment of non-Hodgkin's lymphoma].
Mayer J; Navrátil M; Vásová J; Vorlícek J
Vnitr Lek; 2001 Sep; 47 Suppl 1():57-62. PubMed ID: 11693064
[TBL] [Abstract][Full Text] [Related]
14. Rituximab (anti-CD20 monoclonal antibody) therapy for progressive intermediate-grade non-Hodgkin's lymphoma after high-dose therapy and autologous peripheral stem cell transplantation.
Tsai D; Moore H; Hardy C; Porter D; Loh E; Vaughn D; Luger S; Schuster S; Stadtmauer E
Bone Marrow Transplant; 1999 Sep; 24(5):521-6. PubMed ID: 10482937
[TBL] [Abstract][Full Text] [Related]
15. Atypical progressive multifocal leucoencephalopathy and primary cerebral lymphoma.
Liberski PP; Alwasiak J; Wegrzyn Z
Neuropatol Pol; 1982; 20(3-4):413-9. PubMed ID: 6897851
[No Abstract] [Full Text] [Related]
16. Primary non-Hodgkin's lymphoma in the esophagus.
Zhu Q; Xu B; Xu K; Li J; Jin XL
J Dig Dis; 2008 Nov; 9(4):241-4. PubMed ID: 18959598
[TBL] [Abstract][Full Text] [Related]
17. Progressive multifocal leukoencephalopathy - the importance of early diagnosis illustrated in four cases.
Nived O; Bengtsson AA; Jönsen A; Sturfelt G
Lupus; 2008 Nov; 17(11):1036-41. PubMed ID: 18852230
[TBL] [Abstract][Full Text] [Related]
18. Progressive multifocal leukoencephalopathy following rituximab treatment in a patient with rheumatoid arthritis.
Fleischmann RM
Arthritis Rheum; 2009 Nov; 60(11):3225-8. PubMed ID: 19877057
[TBL] [Abstract][Full Text] [Related]
19. Use of rituximab in combination with conventional chemotherapy for the treatment of non-Hodgkin's lymphoma of the head and neck.
Manolopoulos L; Gomatos IP; Leandros E; Alevizos L; Georgiou N; Giotakis J; Ferekidis E
In Vivo; 2009; 23(3):475-8. PubMed ID: 19454517
[TBL] [Abstract][Full Text] [Related]
20. Inclusion of rituximab in treatment protocols for non-Hodgkin's lymphomas and risk for progressive multifocal leukoencephalopathy.
Tuccori M; Focosi D; Blandizzi C; Pelosini M; Montagnani S; Maggi F; Pistello M; Antonioli L; Fornai M; Pepe P; Rossi G; Petrini M
Oncologist; 2010; 15(11):1214-9. PubMed ID: 21041380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
